Cargando…
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Targeted therapies in endometrial cancer (EC) using kinase inhibitors rarely result in complete tumor remission and are frequently challenged by the appearance of refractory cell clones, eventually resulting in disease relapse. Dissecting adaptive mechanisms is of vital importance to circumvent clin...
Autores principales: | Eritja, Núria, Chen, Bo-Juen, Rodríguez-Barrueco, Ruth, Santacana, Maria, Gatius, Sònia, Vidal, August, Martí, Maria Dolores, Ponce, Jordi, Bergadà, Laura, Yeramian, Andree, Encinas, Mario, Ribera, Joan, Reventós, Jaume, Boyd, Jeff, Villanueva, Alberto, Matias-Guiu, Xavier, Dolcet, Xavier, Llobet-Navàs, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361596/ https://www.ncbi.nlm.nih.gov/pubmed/28055301 http://dx.doi.org/10.1080/15548627.2016.1271512 |
Ejemplares similares
-
Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation
por: Bergadà, Laura, et al.
Publicado: (2014) -
An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias
por: Mirantes, Cristina, et al.
Publicado: (2013) -
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
por: Gatius, Sònia, et al.
Publicado: (2022) -
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
por: Jové, Mariona, et al.
Publicado: (2016) -
In Vivo Intra‐Uterine Delivery of TAT‐Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53‐Deficient Endometrial Cancers
por: Navaridas, Raúl, et al.
Publicado: (2023)